US

James P Mccarron

 

Average Co-Inventor Count = 1.0

ph-index = 1


Loading Chart...

Title: James P. McCarron: Innovator in Pharmaceutical Treatments

Introduction

James P. McCarron is an accomplished inventor based in the United States. He has made significant contributions to the field of pharmaceutical compositions, particularly in the treatment of inflammatory-related diseases. His innovative approach focuses on the administration of specific compounds to address pro-inflammatory cytokine expression.

Latest Patents

James P. McCarron holds a patent for "Methods Of Treating An Inflammatory-Related Disease." This invention relates to pharmaceutical compositions and methods aimed at treating inflammatory-related diseases associated with pro-inflammatory cytokine expression and/or reduced expression of anti-inflammatory cytokines. The method typically involves the administration of one or more compounds selected from isoindigo, indigo, indirubin, or their derivatives, such as Meisoindigo and NATURA. The pharmaceutical composition preferably includes an anti-inflammatory agent and a pharmaceutically acceptable carrier.

Career Highlights

James P. McCarron is currently associated with Natrogen Therapeutics International, Inc. His work focuses on developing innovative treatments that can significantly improve patient outcomes in inflammatory diseases. Despite having no patents listed under his name, his research and contributions are noteworthy in the pharmaceutical industry.

Collaborations

James has collaborated with notable colleagues, including Longgui Wang and Xiao Mei Liu. Their combined expertise enhances the research and development efforts at Natrogen Therapeutics International, Inc.

Conclusion

James P. McCarron is a dedicated inventor whose work in pharmaceutical treatments for inflammatory diseases showcases his commitment to advancing medical science. His innovative methods and collaborations highlight the importance of teamwork in achieving breakthroughs in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…